• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Up 1.09% Nasdaq Up 0.98%

    Arena Pharmaceuticals, Inc. (ARNA)

    -NasdaqGS
    4.08 Up 0.09(2.26%) Jul 28, 4:00PM EDT
    Add to Portfolio
    Prev Close:3.99
    Open:4.04
    Bid:3.88 x 100
    Ask:4.28 x 100
    1y Target Est:7.70
    Beta:-0.62
    Earnings Date:Jul 30 - Aug 3 (Est.)
    Day's Range:3.94 - 4.11
    52wk Range:3.26 - 6.28
    Volume:1,738,008
    Avg Vol (3m):2,719,790
    Market Cap:987.52M
    P/E (ttm):N/A
    EPS (ttm):-0.27
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for ARNA

    Comparison

    Symbol% ChgMkt Cap
    ARNAUp 2.26%987.52M
    GSKUp 0.26%100.73B
    OREXUp 4.28%549.72M
    RHHBYUp 1.33%245.66B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):22.77
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :-0.51
    Quarterly EPS Est (Jun-15) :-0.14
    Mean Recommendation*:2.6
    PEG Ratio (5 yr expected):0.39

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Arena Pharmaceuticals, Inc., a biopharmaceutical company, discovers, develops, and commercializes novel drugs that target G protein-coupled receptors. The company offers BELVIQ, a drug used to treat chronic weight management in adults. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback